A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors
Clinical trial NCT02667873 · COMPLETED
Trial details
- NCT number
- NCT02667873
- Sponsor
- Stemline Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-23
- Primary completion
- 2021-10-06
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.